K9_PD_Kuliah UTI - k8

46
 Urinary Tract Infections Lecture 1: Genito-urinary system.

Transcript of K9_PD_Kuliah UTI - k8

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 1/46

 Urinary Tract Infections

Lecture 1: Genito-urinary system.

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 2/46

Getting Clear on the

Terminology

UTI

Asymptomatic

Bacteriuria

Symptomatic

UTI

Cystitis

Urosepsis

Asymptomatic

UTI

Pylonephritis

Pyuria

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 3/46

3

Infection

Infection is defined as the entry and

multiplication of microorganism(s) in the

tissues of the host that produces injuriouseffects.

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 4/46

4

Cystitis

Infection of the urinary tract limited to the

 bladder, usually involving only the mucosal

surface –  Most common type of UTI in the long-term care

setting

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 5/46

5

Pyelonephritis

Infection of the kidney usually resulting from

travel of the infection from the bladder to the

ureter and then to the kidney.(ascending)

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 6/46

6

Urosepsis

Sepsis occurs when bacteria have entered the

 bloodstream and lead to a widespread

(systemic) inflammatory response.Urosepsis means the infection has stemmed

from an infection of the urinary tract

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 7/46

7

Asymptomatic Bacteriuria

The presence of bacteria in the urine of a

 person without symptoms of infection.

 – 

Should not be called a UTI –  Should not be treated with antibiotics

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 8/46

8

Pyuria

The presence of white blood cells in the urine.

 –  The body’s reaction to invasion by bacteria. 

 – 

One of the key differentiating points betweenUTI and assymptomatic bacteriuria

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 9/46

Getting Clear on the

Terminology

Pollakisuria

Pollakisuria/dysuria

syndrome 

Anuria

Dysuria

Polyuria

Oliguria

Cylindruria

Hematuria

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 10/46

 ◙ The risk of uti in women 10x men.

Why?

the shorter distance between anus andmeatus urethrae externum.

◙ almost half of all women will have at least

one UTI in their lives.◙ the risk of UTI in women increases after

menopause

U.T.I.

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 11/46

 ◙ after a UTI 20 - 40 % will have a recurrence

◙ the recurring infections are usually

re-infections.◙ asymptomatic bacteriuria in women occurs in

2.7% of 15 - 24 year olds

9.3% of over 65 year olds and

20 - 50% of over 80 year olds

U.T.I.

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 12/46

UTI is rare in young and middle-aged men

UTI in men is often associated with catheterisation or

urological procedures.

bacteriuria in elderly men occurs in

 – about 10% of those living at home,

 – about 20% of those living in nursing homes and

 – 30% of those who are in-patients in hospitals

urinary catheter increases the risk almost ten-fold inhospitalised patients and those in other care homes.

pyelonephritis is common in patients who have been

catheterised for over a month.

PREVALENCE

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 13/46

Urinary tract infection occurs when bacteria whichcolonise the anal area ascend  through urethra to the

bladder  

Risk factors include

 – reduced resistance offered by the mucous membranes (e.g.after menopause)

 – sexual intercourse

 – disturbances in ureteral functioning

 – in children the re-entering of urine back into the ureters

(vesicoureteral reflux), which predisposes them particularly

to upper UTI’s

Pathogenesis

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 14/46

Pathogenesis

Other risk factors:

benign prostatic hypertrophy

any illness, such as diabetes, which affects theemptying of the bladder

spinal injury (associated with disturbances inbladder emptying or urinary catheter)

catheterisation in hospital or residential care

other urological procedures

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 15/46

Causative agents of UTIs 

Escherich ia co l i  

 – most common

 – about 80% of primary care infections

 – about 50% of hospital-acquired infections

Others:

 – enterococc i  

 – Staphy lococ cus saprophy t icus  and

 – klebs iel las   – various types of pseudomonas  and proteus are

more rare

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 16/46

’Complicated’ or ’uncomplicated’? 

‘Uncomplicated’ urinary tract infections are

 – occasional lower urinary tract infections in women 

with no predisposing factors to infections

‘Complicated’ infections are all other UTIs including lower

UTIs in

 – pregnant women

 – men

 – children

 – and catheter-induced infections

 – The investigations and treatment of these entail special

features

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 17/46

Symptoms of UTIs 1

Cystitis:

typical symptoms include frequency and burning sensation

when passing urine.

Pyelonephritis:

only some patients have difficulties in micturition

temperature (> 38oC) and flank or back pain

nausea in the elderly or sudden collapse in health status(”off -legs”) 

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 18/46

Symptoms of UTIs 2

incontinence or offensive urine in the elderly should not be

considered as UTI as such; even though they may be

indicative signs of an infection

almost any signs of infection in infants may be indicative of aUTI (C) 

in a small child a temperature alone, without any other signs

of an infection, should raise a suspicion of a UTI

UTI in children and the elderly may manifest itself asincontinence or retention.

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 19/46

Diagnosis of UTIs 

Based on the symptoms both

a clinical diagnosis of a UTI anda differentiation between lower (cystitis) or

upper (pyelonephritis) UTI should be made

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 20/46

Collecting a sample 

in adults and older children a mid stream urine (MSU)sample usually reliably represents the urine in thebladder.

samples collected from urinary bags or bedpansshould not be used to diagnose UTI as they invariablywill be contaminated

the most reliable sample is obtained via a suprapubic

punctureurine in bladder >4 hours (any shorter time willincrease the risk of false negative findings)

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 21/46

Clinically significant pathogen concentrations

Clinical status or methods of sampling

Significantconcentration(microbes / ml)

MSU; symptomatic patient or urine inbladder <4 h

>103

MSU; urine in bladder >4 h >104-5

Male patient, catheter specimen sample >103

Female patient, catheter specimen sample >104

 Asymptomatic bacteriuria >105

Suprapubic puncture sample any growth

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 22/46

Diagnosis of UTIs 1 

No need to do any urinalysis, if a female

patient, who does not belong to any of the

risk groups,

Urine microscopy is not usually necessary to

diagnose cystitis 

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 23/46

Symptomaticpatient

Uncomplicated cystitisin a woman,

no risk factorsnot a relapse

Typical symptoms,

 < 2 infections / year,

patient familiar withher illness

Bacterial culture,

"on the spot" testingto confirm diagnosis

Starttreatment

based onresults

 Antibiotictherapy

 Yes

No

No

 Yes

Diagnosis algorithm

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 24/46

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 25/46

Asymptomatic bacteriuria

Results of urine culture have repeatedly shownbacterial growth above 105 bacteria (cfu)/ml 

possible pyuria does not affect interpretationif several bacterial strains are grown on culture;contamination of the sample is the likely cause

investigations and treatment of asymptomaticbacteriuria should be instigated only in pregnantwomen 

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 26/46

 Antimicrobial therapy in UTIs 1

Acute uncomplicated cystitis:

 – patient with typical symptoms, not belonging to any of therisk groups, is treated without laboratory investigations

 – if the symptoms are atypical, a strip test urinalysis may be

carried out to support diagnosis – if the strip test is negative, the urine should be cultured and

other reasons for the symptoms should be considered

 – First choices: – trimethoprim for 3-5 days

 – nitrofurantoin for 5-7 days or

 – pivmecillinam for 5-7 or 3 days

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 27/46

Antimicrobial therapy in UTIs 2

Reserve drugs:

Quinolones (norfloxacin, ofloxacin or ciprofloxacin) for 3 days

 – if first choice drugs are not suitable or

 – if the infection has not responded to first choice drugs or

 – recurrent infection within 4 weeks

 – if there is a relapse, urine must be cultured and the treatment should becontinued for 7 days

In special cases:

 – cefalexin or cefadroxil for 5 days (if the above are contraindicated)

 – sulphatrimethoprim (SMZ-TM) for 3 days (particularly if the level ofinfection is unclear)

 – amoxicillin for 5 days (particularly in enterococcal infections)

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 28/46

Single-dose therapy

single-dose therapy is slightly less effective than conventional

therapy

effective in infections caused by E. co li , but less so in S.

saprophyticus infections

recommended particularly when practical reasons warrant its

use (e.g. self-care)

Preparations:

 – phosphomycin 3 g – norfloxacin 800 mg

 – ciprofloxacin 500 - 750 mg

 – ofloxacin 200 mg as a single dose

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 29/46

Treatment of pyelonephritis 

Uncomplicated pyelonephritis:

 A pyelonephritis patient who is not unduly ill 

can be looked after at home (C) 

Treatment with either a fluoroquinolone or

sulphatrimethoprim orally for 10-14 days

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 30/46

Treatment of pyelonephritis 2

 An unwell pyelonephritis patient with or without hightemperature should be admitted to hospital

in hospital the treatment is commenced with cefuroxime i.v.0.75-1.5g every 8 hours or with an fluoroquinolone orally

it is usually possible to change over to oral medication withfirst-generation cephalosporins in 2-3 days, when responseto treatment is obvious

third-generation cephalosporins are usually notrecommended for the treatment of uncomplicated

pyelonephritis, but ceftriaxone may be chosen as the initialtherapy, if either once a day or intramuscular administrationare considered beneficial

aminoglycosides have shown no additional benefits overother forms of treatment

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 31/46

Treatment during pregnancy 

Bacteriuria during pregnancy is associated withincreased risk of premature labour and pyelonephritis

 – asymptomatic bacteriuria and cystitis are treated in thesame way

 – single-dose treatment is not recommended

 – drugs of choice

nitrofurantoin 75 mg twice daily for 5 - 7 days or

beta-lactamase (mecillinam, amoxicillin or first-

generation cephalosporins) for 5 – 7 days.

 – due to foetal risk fluoroquinolones should be avoidedduring the whole of pregnancy, and SMZ-TM during the

latter part of pregnancy

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 32/46

Lower UTIs in children

treatment principles are the same as for adults

little evidence to support short term treatment in children

(C) 

drugs of choice

 – nitrofurantoin 5 mg/kg/day or

 – trimethoprim 8 mg/kg/day

 – treatment to continue for 5 days (C) 

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 33/46

Probable lower UTI with generalised

symptoms in children

treated so that any possible infection of the kidney is alsocovered, i.e. with antibiotics with high tissue penetrability

oral medication acceptable

drugs of choice

 – sulphatrimethoprim (trimethoprim 8 mg/kg/day)

 – cefalexin 30 - 50 mg/kg/day in 3 divided doses

 – cefuroxime axetil 20 mg/kg/day in 2 divided doses or

 – mecillinam 20 - 40 mg/kg/day in 3 divided doses – treatment to continue for 7 days (C)

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 34/46

Treatment of pyelonephritis in children 

all infants with febrile UTI should be admitted to hospitaldrugs of choice

 – cefuroxime (100 mg/kg/day in 3 divided doses) or

 – ceftriaxone (80 mg/kg/day daily)

 – intravenous therapy until obvious response

 – when obvious response to treatment is observed,

medication is changed over to oral until the total course of

treatment, i.e. 10 days, is completed

follow-up treatment according to culture and sensitivity

results, with an antibiotic with good tissue penetrability (e.g.

sulphatrimethoprim or a cephalosporin)

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 35/46

UTIs in men

a UTI in men can be associated with either acute or chronic

bacterial prostatitis

prostatitis or epididymitis may play a part particularly in

febrile UTI

it is advisable to palpate both the prostate and scrotum

chronic bacterial prostatitis, or at least the retention of

bacteria in the prostatic ducts, should be suspected in

relapses with the same causative bacteria

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 36/46

UTIs in men 2

Afebrile lower urinary tract infection in men:

if the infection is not associated with urinary stricture or prostatitis,it is

treated with the same drugs as cystitis in women, but the treatment

should continue for 7 - 10 days 

nitrofurantoin should not be used in men as adequate prostatic

concentrations are not achieved (D) 

Febrile urinary tract infection in men is treated with

a long course of antibiotics with good prostatic and epididymalpenetration

first choice:  a fluoroquinolone for 2 weeks

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 37/46

UTIs in men 3

UTI in men associated with acute bacterial prostatitis treatment for 4 - 6 weeks (depending how quickly patient

responds to treatment)

to be followed up with low dose prophylaxis with e.g.

trimethoprim or  nitrofurantoin

Chronic bacterial prostatitis

recurrent UTI’s and calcifications in prostate 

oral quinolones for 2 – 3 months (D) to be followed up with prophylactic medication

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 38/46

Treatment of UTI in diabetics 

Cystitis in diabeticsdrugs of choice for initial treatment are same as for uncomplicated UTI

antibiotic treatment must always be based on the results of urine

culture 

treatment to continue for 7 days

Acute pyelonephritis in diabetics 

treatment is the same as for uncomplicated pyelonephritis

consider urological imaging earlier than normal, if there is no response to

appropriately chosen medication

the causative agents of recurrent UTI’s in diabetics are often unusual,

resistant microbes (species of pseudomonas, enterococci and

enterobacter) and various candida species. 

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 39/46

Prophylaxis of recurrent cystitis with

antimicrobial agents

prophylaxis should be considered when more

than 3 infections per year  

prophylaxis to continue for 6 monthsif infections recur after prophylactic treatment,

the prophylaxis is re-commenced for 6 – 12

months (D)

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 40/46

Drugs of choice in UTI prophylaxis 

First choice: 

trimethoprim 100 mg in the evenings

nitrofurantoin 50 - 75 mg in the evenings

Second choice: 

methenamine hippurate 1 g twice daily

norfloxacin 200 mg daily or on 3 evenings per weeknitrofurantoin (not if serum creatinine is above 150 μmol/l)

quinolones (in cases where there is no response with other

prophylactic medication or tolerance to other medications is poor)

During pregnancy: 

nitrofurantoin 50 mg daily or

methenamine hippurate 1 g daily for the rest of the pregnancy

particularly if recurrent bacteriuria is diagnosed in early pregnancy

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 41/46

Medication to be taken after intercourse

 A single-dose prophylaxis taken after intercourse iseffective in women whose UTI’s are clearly associated with

sexual intercourse (A) 

First choice:

 – trimethoprim 100-300 mg as a single dose

 – nitrofurantoin 50-75 mg as a single dose

Second choice: 

 – norfloxacin 200 mg, ofloxacin 100 mg or ciprofloxacin

100-250 mg

 – sulphatrimethoprim (1 single-strength tablet) 

Th i lit it i f th

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 42/46

The main quality criteria for the

treatment of UTI’s 

urine sample to be collected appropriately when

infection is suspected

unnecessary culturing of urine samples to be

avoided

the investigation and treatment of asymptomatic

bacteriuria to be reserved for risk groups

diagnosing structural anomalies of the urinary tractin children

rational use of antibiotics

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 43/46

Antimicrobial therapy in association with

a urinary catheter 1

the treatment of UTI in a catheterisedpatient should always be based on theidentity and sensitivity of the causative

microbethe catheter should always be removed, atleast for the duration of treatment, asotherwise the bacteria will not be eradicated

if this is not feasible, the recommendation isto continue treatment for 7 - 10 days evenin lower UTI’s 

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 44/46

Antimicrobial therapy in association with

a urinary catheter 2

In the following patient groups antibiotics can prevent serious

infective complications caused by long-term catheterisation :

after renal transplant (for 3 months)

granulocytopenic patients and

possibly in diabeticsit is recommended that drugs which could be of benefit in serious

infections (beta-lactamases and fluoroquinolones) are not used for

prophylaxis 

Antibiotic prophylaxis is not recommended:

for repeat catheterisationsfor the insertion of long-term catheter

for pyuria and bacteriuria in a patient with a long-term catheter but no

obvious infection 

Antimicrobial therapy in association with a urinary

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 45/46

 Antimicrobial therapy in association with a urinary

catheter 3 

Fungal bladder infection in a catheterised patient:

systemic fluconazole is slightly more effective than

topical amphotericin B 

removal of the catheter will improve the eradication of themicrobe during therapy

Suprapubic catheter:

its use is associated with a lower incidence of bacteriuria inpostoperative care

any infections are treated as any other infections

associated with urinary catheters

8/13/2019 K9_PD_Kuliah UTI - k8

http://slidepdf.com/reader/full/k9pdkuliah-uti-k8 46/46

Terima kasih